申请人:ASTRAZENECA AB
公开号:US20030105142A1
公开(公告)日:2003-06-05
The invention concerns amide derivatives of formula (I) wherein R
3
is (1-6C)alkyl or halogeno; Q
1
is heteroaryl which is optionally substituted with 1, 2, 3, or 4 substituents such as hydroxy, halogeno, trifluoromethyl, (1-6C)alkyl, (1-6C)alkoxy, hydroxy-(1-6C)alkyl, (1-6C)alkoxy-(1-6C)alkyl, hydroxy-(2-6C)alkoxy, amino-(2-6C)alkylamino, N-(1-6C)alkyl-(1-6C)alkylamino-(2-6C)alkylamino, aryl, heteroaryl and heterocyclyl; p is 0-2 and R
2
is a substituent such as hydroxy and halogeno; q is 0-4; and Q
2
includes optionally substituted aryl, cycloalkyl, heteroaryl and heterocyclyl; or pharmaceutically-acceptable salts or in vivo-cleavable esters thereof; processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of diseases or medical conditions mediated by cytokines.
本发明涉及式(I)的酰胺衍生物,其中R3是(1-6C)烷基或卤素基;Q1是杂环芳基,可以用1、2、3或4个取代基,例如羟基、卤素基、三氟甲基、(1-6C)烷基、(1-6C)烷氧基、羟基-(1-6C)烷基、(1-6C)烷氧基-(1-6C)烷基、羟基-(2-6C)烷氧基、氨基-(2-6C)烷基氨基、N-(1-6C)烷基-(1-6C)烷基氨基-(2-6C)烷基氨基、芳基、杂环芳基和杂环烷基;p为0-2,R2是羟基和卤素基等取代基;q为0-4;Q2包括可选取代的芳基、环烷基、杂环芳基和杂环烷基;或其药学上可接受的盐或体内可水解的酯;其制备方法、包含它们的制药组合物以及它们在治疗细胞因子介导的疾病或医学状况中的用途。